Literature DB >> 8392591

Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI.

Z Yao1, W Jackson, C Grose.   

Abstract

Varicella-zoster virus (VZV) glycoprotein gpI, the homolog of herpes simplex virus gE, functions as a receptor for the Fc portion of immunoglobulin G. Like other cell surface receptors, this viral receptor is highly phosphorylated in cell culture. To identify the precise location of the cellular kinase-mediated phosphorylation, we generated a tailless deletion mutant and several point mutants which had altered serine and threonine residues within the cytoplasmic domain of gpI. The mutated and wild-type genes of gpI were transfected and expressed within a vaccinia virus-T7 polymerase transfection system in order to determine what effect these mutations had on the phosphorylation state of the protein in vivo and in vitro. Truncation of the cytoplasmic domain of gpI diminished the phosphorylation of gpI in vivo. Examination of the point mutants established that the major phosphorylation sequence of gpI was located between amino acids 593 and 598, a site which included four phosphorylatable serine and threonine residues. Phosphorylation analyses of the mutant and wild-type glycoproteins confirmed that gpI was a substrate for casein kinase II, with threonines 596 and 598 being critical residues. Although the mutant glycoproteins were phosphorylated by casein kinase I, protease V8 partial digestion profiles suggested that casein kinase II exerted the major effect. Thus, these mutagenesis studies demonstrated that the gpI cytoplasmic sequence Ser-Glu-Ser-Thr-Asp-Thr was phosphorylated in mammalian cells in the absence of any other herpesvirus products. Since the region defined by transfection was consistent with results obtained with in vitro phosphorylation by casein kinase II, we propose that VZV gpI is a physiologic substrate for casein kinase II. Immunofluorescence and pulse-chase experiments demonstrated that the mutant glycoproteins were processed and transported to the outer cell membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392591      PMCID: PMC237829     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Casein kinase I and II--multipotential serine protein kinases: structure, function, and regulation.

Authors:  P T Tuazon; J A Traugh
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1991

2.  Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms.

Authors:  C R Lin; W S Chen; C S Lazar; C D Carpenter; G N Gill; R M Evans; M G Rosenfeld
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

Review 3.  Casein kinases--multipotential protein kinases.

Authors:  G M Hathaway; J A Traugh
Journal:  Curr Top Cell Regul       Date:  1982

4.  Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.

Authors:  E A Montalvo; R T Parmley; C Grose
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654.

Authors:  R J Davis; M P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  The complete DNA sequence of varicella-zoster virus.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

7.  Rapid internalization of the transferrin receptor in K562 cells is triggered by ligand binding or treatment with a phorbol ester.

Authors:  R D Klausner; J Harford; J van Renswoude
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Identification of the products of a varicella-zoster virus glycoprotein gene.

Authors:  A J Davison; D J Waters; C M Edson
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

9.  Mechanism of insulin action on membrane protein recycling: a selective decrease in the phosphorylation state of insulin-like growth factor II receptors in the cell surface membrane.

Authors:  S Corvera; M P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material.

Authors:  C M Edson; B A Hosler; C A Poodry; R T Schooley; D J Waters; D A Thorley-Lawson
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

View more
  29 in total

1.  Role of PACS-1 in trafficking of human cytomegalovirus glycoprotein B and virus production.

Authors:  Colin M Crump; Chien-Hui Hung; Laurel Thomas; Lei Wan; Gary Thomas
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

2.  Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection.

Authors:  Barbara Berarducci; Minako Ikoma; Shaye Stamatis; Marvin Sommer; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.

Authors:  S Mallory; M Sommer; A M Arvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope.

Authors:  Lucie Maresova; Tracy Jo Pasieka; Elizabeth Homan; Erick Gerday; Charles Grose
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network.

Authors:  A Alconada; U Bauer; B Hoflack
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

6.  Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells.

Authors:  Stefan L Oliver; Marvin H Sommer; Mike Reichelt; Jaya Rajamani; Leonssia Vlaycheva-Beisheim; Shaye Stamatis; Jason Cheng; Carol Jones; James Zehnder; Ann M Arvin
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

7.  Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Authors:  Barbara Berarducci; Jaya Rajamani; Leigh Zerboni; Xibing Che; Marvin Sommer; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex).

Authors:  Z Yao; C Grose
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase.

Authors:  M Ye; K M Duus; J Peng; D H Price; C Grose
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Intracellular traffic of herpes simplex virus glycoprotein gE: characterization of the sorting signals required for its trans-Golgi network localization.

Authors:  A Alconada; U Bauer; B Sodeik; B Hoflack
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.